Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
Hubert P, Roncarati P, Demoulin S, Pilard C, Ancion M, Reynders C, Lerho T, Bruyere D, Lebeau A, Radermecker C, Meunier M, Nokin MJ, Hendrick E, Peulen O, Delvenne P, Herfs M.
Hubert P, et al. Among authors: delvenne p.
J Immunother Cancer. 2021 Mar;9(3):e001966. doi: 10.1136/jitc-2020-001966.
J Immunother Cancer. 2021.
PMID: 33712445
Free PMC article.